Direct and indirect impact of SARS-CoV-2 on the brain

por Peron, J. P. S.
Publicado 2023

Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer

por Péron, J, Roy, P, Ding, K, Parulekar, W R, Roche, L, Buyse, M
Publicado 2015

Posttraumatic Stress Disorder and Hyperventilation in Post-COVID-19 Syndrome: An Underestimated Association

por Benzakour, L., Voruz, P., Lador, F., Guerreiro, I., Kharat, A., Assal, F., Péron, J.A.
Publicado 2022

Impact de la pandémie de Covid-19 sur les modifications thérapeutiques des patientes atteintes de cancers gynécologiques()

por Lamblin, G., Golfier, F., Peron, J., Moret, S., Chene, G., Nohuz, E., Lebon, M., Dubernard, G., Cortet, M.
Publicado 2020

Monocytosis in the acute phase of SARS-CoV-2 infection predicts the presence of anosognosia for cognitive deficits in the chronic phase

por Nuber-Champier, A., Voruz, P., Jacot de Alcântara, I., Breville, G., Allali, G., Lalive, P.H., Assal, F., Péron, J.A.
Publicado 2022

Subthalamic nucleus stimulation affects orbitofrontal cortex in facial emotion recognition: a pet study

por Le Jeune, F., Péron, J., Biseul, I., Fournier, S., Sauleau, P., Drapier, S., Haegelen, C., Drapier, D., Millet, B., Garin, E., Herry, J.-Y., Malbert, C.-H., Vérin, M.
Publicado 2008

Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E

por Perrin, H. Blasco, Cintas, P., Abravanel, F., Gérolami, R., d'Alteroche, L., Raynal, J.-N., Alric, L., Dupuis, E., Prudhomme, L., Vaucher, E., Couzigou, P., Liversain, J.-M., Bureau, C., Vinel, J.-P., Kamar, N., Izopet, J., Peron, J.-M.
Publicado 2015

Frequency of Abnormally Low Neuropsychological Scores in Post-COVID-19 Syndrome: the Geneva COVID-COG Cohort

por Voruz, P, Jacot de Alcântara, I, Nuber-Champier, A, Cionca, A, Allali, G, Benzakour, L, Lalive, P H, Lövblad, K-O, Braillard, O, Nehme, M, Coen, M, Serratrice, J, Reny, J-L, Pugin, J, Guessous, I, Ptak, R, Landis, B N, Assal, F, Péron, J A
Publicado 2022

Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection

por Nuber-Champier, A., Cionca, A., Breville, G., Voruz, P., de Alcântara, I. Jacot, Allali, G., Lalive, P.H., Benzakour, L., Lövblad, K.-O., Braillard, O., Nehme, M., Coen, M., Serratrice, J., Reny, J.-L., Pugin, J., Guessous, I., Landis, B.N., Griffa, A., De Ville, D. Van, Assal, F., Péron, J.A.
Publicado 2023

Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104]

por Nuber-Champier, A., Cionca, A., Breville, G., Voruz, P., Jacot de Alcântara, I., Allali, G., Lalive, P.H., Benzakour, L., Lövblad, K.-O., Braillard, O., Nehme, M., Coen, M., Serratrice, J., Reny, J.-L., Pugin, J., Guessous, I., Landis, B.N., Griffa, A., Van De Ville, D., Assal, F., Péron, J.A.
Publicado 2023